Press Release
Deal
Deal value₹720 Cr
Deal vs businessorder = 3.21x TTM revenue
Size vs own revenue3.21× — oversized — in the 90-day study 20% of these fell >25%, against 4% of deals under half of revenue
Execution period2.0 yr
Fundamental gradeD
AI projections
Revenue uplift (yr1 / steady)80.0% / 160.7%
EPS uplift150.0%
Upside base / bull / bear60.0% / 150.0% / -50.0%
Horizon24-36 months
Realized market record
Entry — next-day open (27 Mar 2026)₹20.5
Latest close (16 Oct 2026)₹16.19
Return since-21.0%
α vs Smallcap 250-40.7%
α vs own sector-42.9% (Castings & Forgings median +2.2% over 28 matured picks)
Positives
- Massive ₹720 Cr defense order provides strong revenue visibility of ₹30 Cr/month
- Strategic entry into high-margin defense sector (155mm artillery shells) diversifying away from commodity forgings
- Favorable payment terms with a 50% rolling advance on 3 months of supply (approx ₹45 Cr) easing initial working capital
- Ongoing ₹27.97 Cr rights issue could help deleverage and potentially clear the CARE D default status
Risks
- Extremely low promoter holding of 7.87% poses severe governance and alignment risks
- Current CARE D default rating and 'Issuer Not Cooperating' status severely restrict access to bank credit
- High execution risk as the order size is 3.2x TTM revenue, testing the company's 14,400 MTPA capacity and liquidity
- Significant equity dilution (~32%) from the ongoing rights issue will dilute EPS upside
- High dependency on government/defense clearances and potential penalties for delivery delays
Governance flags
- Promoter holding is critically low at 7.87%
- CARE D default credit rating and 'Issuer Not Cooperating' status
- Stretched liquidity with high inventory levels (Inventory Turnover 0.50x)
Full AI brief
1. Ramp-Aware Impact Math
- Current Base: TTM Revenue is ₹224 Cr, TTM PAT is ₹8 Cr, and TTM EPS is ₹1.53 on ~5.22 Cr shares.
- The Order: ₹720 Cr over 24 months translates to ₹360 Cr/year. This is a massive 3.21x TTM revenue.
- Ramp-up Assumptions: Given the company's CARE D default rating and severe liquidity constraints, we assume a conservative 50% execution rate in Year 1 (₹180 Cr revenue recognized, representing an 80% uplift) and 100% execution in Year 2 (₹360 Cr revenue, representing a 160.7% uplift).
- Margin & Profitability: Current OPM is 4.9%. Defense orders typically command higher margins. Assuming a conservative 10% OPM on the defense contract, Year 2 operating profit from this order would be ₹36 Cr. Assuming a 5% net profit margin (after interest and depreciation), the defense order could add ₹18 Cr to PAT at steady state.
- Dilution Impact: The ongoing Rights Issue of 1.677 Cr shares at ₹16.68 will increase the share count from ~5.22 Cr to ~6.90 Cr (~32% dilution).
- Steady-State EPS: Combined PAT (Base ₹8 Cr + Defense ₹18 Cr = ₹26 Cr) divided by post-dilution shares (6.90 Cr) yields a steady-state EPS of ₹3.77, a ~146% increase over current TTM EPS.
2. Industry Capital-Intensity & CAGR
- Capital Intensity: HIGH. Forging and defense shell manufacturing require heavy machinery, specialized tooling, and high working capital.
- Industry CAGR: Estimated at 15% structurally, driven by domestic defense indigenization and railway modernization.
- Execution Difficulty: HIGH. Transitioning from industrial flanges to 155mm artillery shells requires stringent defense clearances, raw material sourcing, and precise manufacturing tolerances.
3. Multibagger Quality Assessment
- Financials: Trailing ROCE is weak at 8.0%, and debt is high at ₹63 Cr (D/E of 0.55). The CARE D rating is a major red flag indicating active default.
- Promoter Alignment: Promoter holding is critically low at 7.87%, which is a severe governance risk and limits long-term conviction.
- Catalyst Credibility: The order is highly material but faces immense execution hurdles due to the lack of bank credit and working capital.
4. Scenario Analysis
- Bull Case (Upside 150%): Successful rights issue subscription clears default status; defense order executed on time with 12% OPM; EPS reaches ₹4.50; stock re-rates to 15x P/E (₹67.5).
- Base Case (Upside 60%): Partial execution delays; 8% OPM achieved; EPS reaches ₹2.50; stock trades at 11x P/E (₹27.5).
- Bear Case (Downside -50%): Rights issue fails or is undersubscribed; working capital starvation leads to order cancellation; default continues; stock falls to ₹8.60.
5. Verdict Rationale
- Capped at POSSIBLE with a low confidence score of 0.30. While the ₹720 Cr order is transformative on paper, the combination of a CARE D credit rating, extremely low promoter holding (7.87%), and substantial equity dilution makes execution highly speculative.
Analysis as of 2026-03-26 (price ₹17.25) ·
AI research, not investment advice.
FollowTelegram
